SLC2A1 and cancer: The strict reliance of SCCs on glucose to maintain redox homeostasis renders such cancers vulnerable to perturbations in glucose uptake, and Goodwin et al. indeed demonstrate the in vivo anticancer effects of GLUT1 and glycolytic inhibition via WZB117 and 2-deoxy-D-glucose (2DG), respectively, in LSCCs [76].